BIOADVANCE
BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new $50 million Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date they have committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies.
BIOADVANCE
Social Links:
Industry:
Biotechnology Life Science Venture Capital
Founded:
2003-07-02
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Domain Not Resolving Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
ARCH Venture Partners
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
ATEM Capital Fund LP
ATEM Capital Fund LP is a venture capital fund that invests in breakthrough technologies in Life Sciences.
BIOCOM
Biocom is one of the largest regional life science association in the world
BioXplor
BioXplor is an AI data-driven Platform for life science discoveries.
Antylia Scientific
Antylia Scientific is a global leader in peristaltic and single use bioprocessing solutions and life sciences
CTI Capital
CTI Capital is a venture capital fund that invests in development-stage, Canadian life sciences companies.
Early Stage Partners
Early Stage Partners is a Midwest-based investment firm that provides early-stage venture capital financing to entrepreneurial companies.
GFBiochemicals
GFBiochemicals company to produce levulinic acid at commercial scale directly from biomass.
Hamilton
Hamilton specializes in precision measurement devices, automated liquid handling workstations, and sample management.
Lilly Asia Ventures
Lilly Asian Ventures is an investment firm that invests in promising life science companies.
Lilly Ventures
Lilly Ventures is an Indiana-based venture capital firm that provides investment to companies in the life sciences sector.
MB Venture Partners
MB Venture Partners is a Tennessee-based venture capital firm that specializes in investments in the life sciences sector.
M Ventures
M Ventures invests in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.
Panorama Capital
Panorama Capital invests in passionate entrepreneurs building leading companies in life sciences and technology.
Pivotal bioVenture Partners
Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies
Pontifax
Pontifax is a venture capital firm that finances pharmaceutical and life sciences companies.
Radicle Growth
Radicle Growth is a San Diego, California based accelerator and venture capital firm focused early-stage ag and food tech startups.
Wisconsin Investment Partners
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members.
WPSS.bio
WPSS.bio is a venture capital firm that invests in revolutionary diagnostics and treatments for central nervous system health.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Innervace | BioAdvance investment in Series A - Innervace | 40 M USD |
| 2022-07-21 | Senzo | BioAdvance investment in Seed Round - Senzo | 2 M USD |
| 2022-07-11 | Halo Labs | BioAdvance investment in Series C - Halo Labs | 6 M USD |
| 2022-03-16 | KayoThera | BioAdvance investment in Series A - KayoThera | 8 M USD |
| 2021-10-28 | Phrase Health | BioAdvance investment in Seed Round - Phrase Health | 3 M USD |
| 2020-06-11 | Wellsheet | BioAdvance investment in Series A - Wellsheet | 3.8 M USD |
| 2020-05-28 | Palvella Therapeutics | BioAdvance investment in Series C - Palvella Therapeutics | 45 M USD |
| 2020-04-06 | Halo Labs | BioAdvance investment in Series B - Halo Labs | 12 M USD |
| 2020-01-07 | Ride Health | BioAdvance investment in Seed Round - Ride Health | 6.2 M USD |
| 2019-08-15 | Renovacor | BioAdvance investment in Series A - Renovacor | 11 M USD |
More informations about "BioAdvance"
Home | BioAdvanceSupport.ca
Personalized support provided for over 179,000 patients across Canada to date* For patients—their BioAdvance ® Coordinator is their champion and stays with them throughout the treatment process, providing information and guidance …See details»
Home | BioAdvance
BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.See details»
Welcome To Bioadvance
Welcome To BioadvanceSee details»
Janssen Canada Access and Affordability Support for Patients
Sep 19, 2024 Patients who are already enrolled in BioAdvance ® should reach out to their care coordinator to discuss their options. Patients who are not already enrolled in BioAdvance ® …See details»
Contact Us | BioAdvanceSupport.ca
CONTACT US WE’RE HERE TO PROVIDE ONE-ON-ONE SUPPORT FOR YOU AND YOUR PATIENTS. Getting started with the Janssen BioAdvance ® program is easy.. If you would like to learn more about the program, including how it …See details»
Login Template Title - BioAdvance® member
The Janssen BioAdvance® program was created to provide patients a connected kind of care, offering comprehensive support throughout the treatment process. As a Janssen BioAdvance® member, you’ll get exclusive access to all the …See details»
BioAdvance - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... BioAdvance is a $80-million …See details»
Welcome To Bioadvance - Salesforce
Français Click one of the following based on your profile: Health Care Professionals. Clinic Service ProfessionalsSee details»
Barbara S. Schilberg - Managing Director
Primary Organization . BioAdvance . Gender Female; Investor Type Investment Partner ... BioAdvance has committed $24.2 million to 36 seed-stage companies and 21 pre-seed projects focusing in areas including Alzheimer's disease, …See details»
BioAdvance - Crunchbase Investor Profile & Investments
BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies. Read More. Lists Featuring This Company. Edit Lists Featuring This Company Section. Female Founded …See details»
BioAdvance - Investments, Portfolio & Company Exits - Crunchbase
BioAdvance 's most notable exits include Immunome, Annovis Bio, and Renovacor. Which industries has this organization had the most exits in? Show . Immunome Immunome is a …See details»
Welcome To Bioadvance
English Cliquez sur l'un des éléments suivants en fonction de votre profil: Professionnels de la santé. Professionnels en cliniqueSee details»
Marnie McCoy - BioAdvance
As program director at BioAdvance, Ms. McCoy is responsible for the maintaining the organization’s outreach to applicants and for internal facilitation of the funding application and …See details»
BioAdvance Announces ~$7M in Recent Investments and …
BioAdvance has greater resources than ever before to help emerging companies and entrepreneurs. Shahram is the right person to take the organization to the next level, and I’m …See details»
Accueil | BioAdvanceSupport.ca
Le coordonnateur BioAdvance ® est un partenaire en soins de santé attitré et expérimenté. Que vous soyez un professionnel de la santé ou un patient, lorsque vous vous inscrivez au …See details»
BioAdvance Announces ~$7M in Recent Investments and …
Sep 29, 2021 BioAdvance is a $70 million early-stage life sciences fund with a focus in the mid-Atlantic region, investing up to $1.5 million initially and up to $5 million in the lifetime of …See details»
BioAdvance Announces ~$7M in Recent Investments and …
Sep 30, 2021 Barbara Schilberg retiring as Managing Director and CEO; Shahram Hejazi, Ph.D., appointed as Managing Director and CEO. PHILADELPHIA, Sept. 29, 2021 /PRNewswire/ — …See details»
BioAdvance
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases. Led by industry innovator Francisco Leon, M.D., …See details»
Biologics and Biosimilars - Janssen Canada
Sep 19, 2024 What is a biologic? Biologic drugs come from living organisms or from their cells, and are often made using biotechnology. They are used to treat diseases and medical …See details»